...
首页> 外文期刊>Cancer Chemotherapy and Pharmacology >Dihydroartemisinin improves the efficiency of chemotherapeutics in lung carcinomas in vivo and inhibits murine Lewis lung carcinoma cell line growth in vitro
【24h】

Dihydroartemisinin improves the efficiency of chemotherapeutics in lung carcinomas in vivo and inhibits murine Lewis lung carcinoma cell line growth in vitro

机译:双氢青蒿素可提高体内肺癌化学疗法的效率并抑制鼠Lewis肺癌细胞系的体外生长

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Purpose Dihydroartemisinin (DHA), a semi-synthetic derivative of artemisinin, has exhibited the strongest antimalarial activity among the derivatives of artemisinin. There is growing evidence that DHA has some impact against tumors. Our purpose was to evaluate in vitro antitumoral properties of DHA in the murine Lewis lung carcinoma (LLC) cell line. At the same time, we observed the therapeutic effect of DHA combined with cyclophosphamide (CTX) in the LLC and combined with cisplatin (CDDP) in the human non-small cell lung cancer A549 xenotransplanted carcinoma in vivo.
机译:目的青蒿素的半合成衍生物二氢青蒿素(DHA)在青蒿素的衍生物中表现出最强的抗疟活性。越来越多的证据表明DHA对肿瘤有一定影响。我们的目的是评估DHA在小鼠Lewis肺癌(LLC)细胞系中的体外抗肿瘤特性。同时,我们观察了DHA联合LLC中的环磷酰胺(CTX)和顺铂(CDDP)在人非小细胞肺癌A549异种移植体内的治疗效果。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号